Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)
Clinical trial NCT06855628 · SUSPENDED
Trial details
- NCT number
- NCT06855628
- Sponsor
- Stanford University
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-30
- Primary completion
- 2028-02-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.